To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STK32CTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
143 supporting clones for gene STK32C back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA532607 brain .a 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DB317756 brain .a 1274 to 1799 526 to 1   tiling clone,   526/526
(100 %)
0 diff
(100 %id)
AK302102 testis .b 1 to 1980 1 to 1980 V4A tiling clone,   1980/1980
(100 %)
1 diff
(100.0 %id)
DC397593 testis .b 1 to 569 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DA364526 subthalamic nucleus .b 412 to 975 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CV029028 mixed .b 477 to 1045 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
TI_1948085629   .b 477 to 1277 131 to 934       804/1511
(53 %)
21 diff
(98.7 %id)
TI_1948085934   .b 477 to 1254 133 to 912       780/1437
(54 %)
33 diff
(97.8 %id)
TI_1948086095   .b 477 to 1154 132 to 812       681/1450
(46 %)
12 diff
(99.2 %id)
DR158101 human embryonic stem cells differentiated toan early endodermal cell type .b 534 to 1314 23 to 803       781/803
(97 %)
6 diff
(99.3 %id)
BI060601 uterus_tumor .b 598 to 878 281 to 1       281/291
(96 %)
5 diff
(98.3 %id)
R87679 brain .b 660 to 800 36 to 176       141/176
(80 %)
1 diff
(99.5 %id)
R88484 brain .b 665 to 836 1 to 172       172/172
(100 %)
6 diff
(96.6 %id)
CX752047 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 693 to 1368 1 to 673       673/878
(76 %)
15 diff
(98.3 %id)
TI_154170887   .b 850 to 1383 94 to 629       536/1030
(52 %)
8 diff
(99.3 %id)
BG282899 adenocarcinoma, cell line, Prostate .b 864 to 1634 1 to 775       775/889
(87 %)
21 diff
(97.7 %id)
BG820170 anaplastic oligodendroglioma with 1p/19qloss, brain .b 990 to 1380 1 to 389       389/389
(100 %)
4 diff
(99.0 %id)
BX390945   .b 1002 to 1869 37 to 898       862/898
(95 %)
16 diff
(98.3 %id)
BM827134 Ascites, stomach .b 1409 to 1725 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BX416707 neuroblastoma .c 1 to 1110 1 to 1104   tiling clone,   1104/1104
(100 %)
13 diff
(98.9 %id)
BX416706 neuroblastoma .c 1348 to 2159 812 to 1   tiling clone,   812/812
(100 %)
19 diff
(97.7 %id)
AY098866   .d 1 to 2119 1 to 2121 exact tiling clone, AAA   2121/2121
(100 %)
4 diff
(99.9 %id)
NM_173575.2   .d 1 to 2119 1 to 2119 exact RefSeq, AAA   2119/2119
(100 %)
0 diff
(100 %id)
DB477143 hippocampus .d 25 to 527 1 to 504       504/504
(100 %)
4 diff
(99.3 %id)
DB482766 hippocampus .d 25 to 527 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
BX384918   .d 41 to 1016 1 to 989       986/989
(99 %)
17 diff
(98.3 %id)
BX384945   .d 107 to 1096 1 to 990       990/990
(100 %)
4 diff
(99.6 %id)
BX342288   .d 139 to 1016 3 to 882       880/882
(99 %)
8 diff
(99.1 %id)
BX403279   .d 139 to 705 3 to 577       575/818
(70 %)
32 diff
(96.1 %id)
CR595271 B cells (Ramos cell line) Cot 25-normalized .d 211 to 2117 1 to 1907   tiling clone,   1907/1907
(100 %)
0 diff
(100 %id)
BX401698   .d 211 to 1132 1 to 922       922/922
(100 %)
1 diff
(99.9 %id)
BI917132 brain .d 247 to 1016 1 to 768       768/773
(99 %)
3 diff
(99.7 %id)
TI_57242422   .d 247 to 1016 69 to 836       768/841
(91 %)
8 diff
(99.1 %id)
DA203024 brain .d 318 to 889 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG824303 adenocarcinoma cell line, colon .d 330 to 1132 1 to 804   available from MGC,   804/1000
(80 %)
21 diff
(97.9 %id)
BC015792 Colon, adenocarcinoma .d 331 to 2119 1 to 1791   available from MGC, AAA   1791/1791
(100 %)
3 diff
(99.9 %id)
DN998812 bone marrow .d 365 to 920 2 to 557       556/557
(99 %)
6 diff
(99.0 %id)
BX362859   .d 457 to 918 1 to 463       463/550
(84 %)
42 diff
(92.4 %id)
CB155747 brain .d 915 to 1533 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BI223604 cervical carcinoma cell line, cervix .d 930 to 1616 1 to 693       693/803
(86 %)
44 diff
(94.6 %id)
AW245503 lung, small cell carcinoma .d 992 to 1506 10 to 524       515/524
(98 %)
7 diff
(98.7 %id)
BI257653 cervical carcinoma cell line, cervix .d 1307 to 2117 2 to 813   AAA   812/813
(99 %)
21 diff
(97.5 %id)
BX362858   .d 1392 to 2092 700 to 1       700/700
(100 %)
3 diff
(99.6 %id)
AW245946 lung, small cell carcinoma .d 1603 to 2119 529 to 11   AAA   519/519
(100 %)
2 diff
(99.7 %id)
DA050175   .e 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
DB296226   .e 1513 to 2029 517 to 1   tiling clone,   517/517
(100 %)
0 diff
(100 %id)
AK057849 brain .f 1 to 1865 2 to 1868 exact tiling clone, available from FLJ,   1868/1868
(100 %)
6 diff
(99.7 %id)
BG719068 testis .g 1 to 806 1 to 807   tiling clone,   807/869
(92 %)
8 diff
(99.1 %id)
BC045760 testis .g 6 to 2015 1 to 2012 T217A tiling clone, available from MGC, AAA   2012/2012
(100 %)
4 diff
(99.9 %id)
DB446031 testis .g 8 to 273 1 to 266       266/416
(63 %)
1 diff
(99.8 %id)
DB449222 testis .g 8 to 429 1 to 422       422/422
(100 %)
0 diff
(100 %id)
DB461997 testis .g 25 to 509 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
F07785 brain, total brain .g 591 to 913 1 to 323       323/323
(100 %)
0 diff
(100 %id)
H16883 whole brain .g 591 to 1017 1 to 434       434/505
(85 %)
15 diff
(97.1 %id)
TI_153963426   .g 1336 to 2012 78 to 755       678/684
(99 %)
7 diff
(99.0 %id)
BM702426 eye, optic nerve .g 1337 to 1939 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
DA091046 cerebellum .g 1340 to 1893 2 to 556   capped   555/555
(100 %)
4 diff
(99.3 %id)
BF513739   .g 1354 to 1808 29 to 483     Submitted on the opposite strand 455/466
(97 %)
0 diff
(100 %id)
BM825032 Ascites, stomach .g 1382 to 1789 1 to 408       408/408
(100 %)
6 diff
(98.6 %id)
CA432719 cell lines, Chondrosarcoma .g 1426 to 2013 608 to 19   AAA   590/590
(100 %)
2 diff
(99.7 %id)
BX393287   .g 1457 to 1982 566 to 39       528/663
(79 %)
0 diff
(100 %id)
BM666731 eye, human retina .g 1502 to 2013 530 to 19   AAA   512/512
(100 %)
0 diff
(100 %id)
BX108840 whole brain .g 1503 to 2014 529 to 15   AAA   515/515
(100 %)
3 diff
(99.5 %id)
CD369442 Alveolar Macrophage, lung .g 1514 to 2022 527 to 19   tiling clone, AAA   509/509
(100 %)
1 diff
(99.9 %id)
BF446773 carcinoid, lung .g 1520 to 2016 504 to 6       499/504
(99 %)
0 diff
(100 %id)
AW024254 thymus, pooled .g 1528 to 2016 491 to 1       491/491
(100 %)
3 diff
(99.4 %id)
BE504290 carcinoid, lung .g 1543 to 2016 477 to 2       476/477
(99 %)
0 diff
(100 %id)
BM805368 brain, hippocampus .g 1543 to 2013 1 to 473       473/1291
(36 %)
5 diff
(99.7 %id)
DB527418 testis .g 1545 to 2022 1 to 480     Submitted on the opposite strand 480/480
(100 %)
3 diff
(99.4 %id)
DB567590 hypothalamus .g 1545 to 2015 1 to 474     Submitted on the opposite strand 474/474
(100 %)
13 diff
(97.3 %id)
DB553092 hippocampus .g 1552 to 2015 1 to 466     Submitted on the opposite strand 466/466
(100 %)
2 diff
(99.6 %id)
AW473633 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g 1555 to 2015 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
BE220639 carcinoid, lung .g 1555 to 2016 465 to 2       464/465
(99 %)
0 diff
(100 %id)
AW073246 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .g 1568 to 2012 447 to 1       447/455
(98 %)
7 diff
(98.5 %id)
AI937540 anaplastic oligodendroglioma, brain .g 1569 to 2016 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AW467235 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .g 1569 to 2013 455 to 11   AAA   445/445
(100 %)
1 diff
(99.8 %id)
DB569283 hypothalamus .g 1570 to 2015 1 to 448   AAA Submitted on the opposite strand 448/448
(100 %)
5 diff
(98.9 %id)
AW014700   .g 1584 to 2013 449 to 18   AAA   432/432
(100 %)
3 diff
(99.4 %id)
DB514248 testis .g 1586 to 2015 1 to 434     Submitted on the opposite strand 434/434
(100 %)
18 diff
(95.9 %id)
AI888173 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 1588 to 2016 437 to 7       431/437
(98 %)
0 diff
(100 %id)
AI014704 pooled .g 1599 to 2012 428 to 13   AAA   416/416
(100 %)
3 diff
(99.3 %id)
AI150220   .g 1604 to 2013 422 to 10       413/422
(97 %)
0 diff
(100 %id)
AI814894 adenocarcinoma, Pancreas .g 1608 to 2013 435 to 27   AAA   409/409
(100 %)
16 diff
(96.1 %id)
AA826850 epithelium (cell line), Prostate .g 1632 to 2008 383 to 7       377/383
(98 %)
0 diff
(100 %id)
H16774 whole brain .g 1636 to 2014 408 to 14   AAA   395/400
(98 %)
22 diff
(94.5 %id)
AI623480 adenocarcinoma, Pancreas .g 1649 to 2013 375 to 9       367/375
(97 %)
0 diff
(100 %id)
AA224147 brain, neuroepithelial cells .g 1657 to 2012 356 to 1       356/356
(100 %)
5 diff
(98.6 %id)
AW733131 Kidney, renal cell adenocarcinoma .g 1680 to 2012 353 to 21   AAA   333/333
(100 %)
28 diff
(91.6 %id)
AI240078 pooled .g 1685 to 2013 338 to 8       331/338
(97 %)
0 diff
(100 %id)
AW664778 pooled .g 1694 to 2013 324 to 5       320/324
(98 %)
0 diff
(100 %id)
AA835060   .g 1711 to 2013 309 to 8       302/309
(97 %)
0 diff
(100 %id)
EC562046 Prostate .g 1723 to 1823 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AI242059 liver and spleen .g 1761 to 2015 257 to 1       257/257
(100 %)
4 diff
(98.5 %id)
Z40867 brain, total brain .g 1813 to 2014 204 to 1       204/204
(100 %)
2 diff
(99.1 %id)
AI564857 anaplastic oligodendroglioma, brain .g 1861 to 2012 193 to 40   AAA   154/155
(99 %)
8 diff
(94.9 %id)
AW470739 2 pooled tumors (clear cell type), Kidney .g 1896 to 2012 125 to 7       119/125
(95 %)
0 diff
(100 %id)
DB243286 stomach, tumor tissue .h 1 to 515 2 to 516   tiling clone, capped   515/515
(100 %)
1 diff
(99.9 %id)
BM749615 stomach .h 12 to 496 10 to 492       485/493
(98 %)
14 diff
(97.2 %id)
CA454976   .h 24 to 868 1 to 851 A141G P142S E143G I144D F145L ... tiling clone,   851/851
(100 %)
7 diff
(99.2 %id)
AK308956 caudate nucleus .i 1 to 1115 6 to 1120 exact tiling clone,   1120/1120
(100 %)
8 diff
(99.3 %id)
DA270972 caudate nucleus .i 1 to 568 6 to 574   capped   573/573
(100 %)
8 diff
(98.7 %id)
TI_57238886   .i 1 to 754 28 to 782       756/782
(96 %)
8 diff
(99.0 %id)
BI915617 brain .i 3 to 754 1 to 754   tiling clone,   754/754
(100 %)
5 diff
(99.4 %id)
DA574949   .j 1 to 545 5 to 549   tiling clone, capped   548/555
(98 %)
6 diff
(99.0 %id)
CN430663 embryonic stem cells, DMSO-treated H9 cellline .j 3 to 475 9 to 481       473/481
(98 %)
7 diff
(98.6 %id)
CN430664 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 12 to 648 1 to 638 G35R tiling clone,   638/638
(100 %)
6 diff
(99.1 %id)
BF980704 duodenal adenocarcinoma, cell line, small intestine .j 18 to 767 1 to 746 H30Y G35R     746/1035
(72 %)
23 diff
(97.8 %id)
AL037116 brain .j 29 to 579 572 to 20 exact tiling clone, AAA   553/554
(99 %)
6 diff
(99.0 %id)
AW236108 Kidney .j 125 to 586 460 to 1       460/460
(100 %)
4 diff
(99.2 %id)
AW058498 Kidney .j 126 to 586 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
BM833108 stomach .j 206 to 579 1 to 373   AAA   373/373
(100 %)
1 diff
(99.8 %id)
AA744883 breast .j 236 to 583 362 to 17   AAA   346/346
(100 %)
5 diff
(98.6 %id)
BQ310187 breast .j 412 to 586 12 to 184       173/192
(90 %)
8 diff
(95.9 %id)
BE009030 breast_normal .j 494 to 895 405 to 1     Submitted on the opposite strand 405/405
(100 %)
13 diff
(96.8 %id)
AW770528 carcinoid, lung .j 587 to 1014 430 to 3   tiling clone,   428/430
(99 %)
0 diff
(100 %id)
AK310725 thymus .k 1 to 1287 2 to 1288   tiling clone,   1288/1288
(100 %)
4 diff
(99.7 %id)
DB158364 thymus .k 1 to 584 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
BG723755 testis .l-u -8 to 722 1 to 726   available from MGC,   726/728
(99 %)
18 diff
(97.6 %id)
BC042566 testis .l-u 1 to 1557 5 to 1555 F34L L35R R36W W37S S38L ... tiling clone, available from MGC, AAA   1555/1555
(100 %)
20 diff
(98.8 %id)
TI_57175865   .l-u 1 to 652 68 to 721       655/876
(74 %)
15 diff
(98.3 %id)
BI752923 brain .l-u 1 to 643 1 to 644       644/921
(69 %)
10 diff
(99.0 %id)
TI_57219747   .l-u 1 to 643 35 to 678       644/955
(67 %)
6 diff
(99.4 %id)
BI829121 brain, medulla .l-u 2 to 652 1 to 653   tiling clone,   653/808
(80 %)
15 diff
(98.2 %id)
DR006579 Spleen .l-u 18 to 602 7 to 591   tiling clone,   585/591
(98 %)
6 diff
(99.0 %id)
BM720428 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .l-u 1190 to 1557 1 to 369   fully sequenced, AAA   369/369
(100 %)
3 diff
(99.2 %id)
AA782619 parathyroid gland, parathyroid tumor .l-u 1196 to 1568 381 to 6   tiling clone,   376/381
(98 %)
0 diff
(100 %id)
BM678768 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .l-u 1364 to 1557 213 to 19   fully sequenced, AAA   195/195
(100 %)
0 diff
(100 %id)
CR985566 T-Lymphocytes .m 1 to 429 1 to 430 E129X H138P E139* tiling clone,   430/430
(100 %)
1 diff
(99.8 %id)
CD674243 eye, lens .n 1 to 568 1 to 568 exact tiling clone,   568/568
(100 %)
1 diff
(99.9 %id)
BF508609   .n 33 to 631 616 to 18 exact tiling clone, AAA   599/609
(98 %)
1 diff
(99.9 %id)
DN997246 breast cancer, Mammary gland (cancer tissue) .n 33 to 626 8 to 601 I41V A45V R50P S51P L118M ...     594/601
(98 %)
9 diff
(98.6 %id)
AA401670   .n 87 to 322 1 to 235   fully sequenced,   235/235
(100 %)
3 diff
(98.8 %id)
AI936830 anaplastic oligodendroglioma, brain .n 160 to 629 472 to 3       470/472
(99 %)
3 diff
(99.4 %id)
BF508271   .n 194 to 628 452 to 18   AAA   435/435
(100 %)
7 diff
(98.4 %id)
AI183653   .n 195 to 639 447 to 3   tiling clone,   445/447
(99 %)
4 diff
(99.2 %id)
AI368429 brain, glioblastoma (pooled) .n 275 to 624 350 to 1       350/350
(100 %)
4 diff
(98.9 %id)
AI024382   .n 280 to 629 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AA398890   .n 292 to 629 337 to 3   fully sequenced,   335/337
(99 %)
0 diff
(100 %id)
BF508268   .n 297 to 628 350 to 18   AAA   333/333
(100 %)
14 diff
(95.8 %id)
AI867824 pooled germ cell tumors .n 318 to 631 314 to 1   tiling clone,   314/314
(100 %)
0 diff
(100 %id)
DW426014 Liver .n 405 to 628 8 to 231   AAA   224/231
(96 %)
7 diff
(97.0 %id)
DA357169 subthalamic nucleus .o 1 to 560 2 to 561   tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
DA062475 cerebellum .o 64 to 624 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
BF449072 Prostate .p 1 to 428 432 to 4 G7R T68N Q69A T70D Q71S ... tiling clone,   429/432
(99 %)
2 diff
(99.6 %id)
AA864269 Kidney, kidney tumor .p 65 to 426 361 to 1   tiling clone,   361/361
(100 %)
1 diff
(99.8 %id)
DA360434 subthalamic nucleus .q 1 to 538 2 to 539 exact tiling clone, capped   538/538
(100 %)
0 diff
(100 %id)
DB044169 testis .r 1 to 561 2 to 566 exact tiling clone, capped   565/565
(100 %)
6 diff
(99.0 %id)
DA710094   .s 1 to 527 2 to 528 H30Y G35R tiling clone, capped   527/527
(100 %)
6 diff
(98.9 %id)
AK098366 brain Gene STK32C, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
DB298575 cerebellum Gene STK32C, variant not shown         This clone was ignored    
DA094609 cerebellum Gene STK32C, variant not shown       capped This clone was ignored    
CF140457 CNCAP(3)T-225 cell line, Prostate Gene STK32C, variant not shown         Suspected internal deletion, this clone was ignored    
DB128460 thymus Gene STK32C, variant not shown       capped This clone was ignored    
DB344417 thymus Gene STK32C, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C